期刊文献+

A review of vasopeptidase inhibitors in heart failure

A review of vasopeptidase inhibitors in heart failure
原文传递
导出
摘要 Background The incidence of acute myocardial infarction(AMI) has become an important social health problem throughout the world. Heart failure after AMI could significantly affect the life quality of patients. Drug therapy has great significance role in inhibiting the remodeling of the cardiac muscle. Vasopeptidase inhibitors(VPIs) could overcome some limitations of traditional drugs by improving the quality of life. This article is aimed to review the progress in the study of VPI drugs and several ways of preventing and controlling heart failure after AMI. Background The incidence of acute myocardial infarction(AMI) has become an important social health problem throughout the world. Heart failure after AMI could significantly affect the life quality of patients. Drug therapy has great significance role in inhibiting the remodeling of the cardiac muscle. Vasopeptidase inhibitors(VPIs) could overcome some limitations of traditional drugs by improving the quality of life. This article is aimed to review the progress in the study of VPI drugs and several ways of preventing and controlling heart failure after AMI.
作者 LUO Chang-jun XIONG Si ZHAO Dana ZOU Jun HUANG An-hong 罗长军;熊思;赵丹;邹军;黄安红(Department of Cardiology, Liuzhou Municipal Liutie Central Hospital;Department of Cardiology, Nanhai People's Hospital;Nanfang Hospital, Southern Medical University)
出处 《South China Journal of Cardiology》 CAS 2017年第3期243-248,共6页 岭南心血管病杂志(英文版)
基金 supported by Projects of provincial health and family planning commission of Guangxi(No.Z2016271/Z20170024/Z20170021)
关键词 vasopeptidase inhibitors acute myocardial infarction heart failure vasopeptidase inhibitors acute myocardial infarction heart failure
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部